Page last updated: 2024-09-03

t-butyloxycarbonyl-methionyl-leucyl-phenylalanine and interleukin-8

t-butyloxycarbonyl-methionyl-leucyl-phenylalanine has been researched along with interleukin-8 in 2 studies

Compound Research Comparison

Studies
(t-butyloxycarbonyl-methionyl-leucyl-phenylalanine)
Trials
(t-butyloxycarbonyl-methionyl-leucyl-phenylalanine)
Recent Studies (post-2010)
(t-butyloxycarbonyl-methionyl-leucyl-phenylalanine)
Studies
(interleukin-8)
Trials
(interleukin-8)
Recent Studies (post-2010) (interleukin-8)
220423,5231,1679,990

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ciccarelli, A; Cirillo, R; de Crescenzo, G; de Paulis, A; Marone, G; Patella, V1
Davidson, BA; Knight, PR; Morrill, SA; Murphy, PM; Olson, R; Russo, TA; Topolnycky, DM1

Other Studies

2 other study(ies) available for t-butyloxycarbonyl-methionyl-leucyl-phenylalanine and interleukin-8

ArticleYear
Cyclosporin H is a potent and selective competitive antagonist of human basophil activation by N-formyl-methionyl-leucyl-phenylalanine.
    The Journal of allergy and clinical immunology, 1996, Volume: 98, Issue:1

    Topics: Basophils; Binding, Competitive; Bryostatins; Chemokine CCL2; Chemokine CCL5; Complement C5a; Cyclosporine; Histamine Release; Humans; Interleukin-1; Interleukin-8; Kinetics; Lactones; Leukotriene C4; Macrolides; N-Formylmethionine Leucyl-Phenylalanine; Oligopeptides; Platelet Activating Factor; Protein Binding; Tetradecanoylphorbol Acetate

1996
Human neutrophil chemotaxis is modulated by capsule and O antigen from an extraintestinal pathogenic Escherichia coli strain.
    Infection and immunity, 2003, Volume: 71, Issue:11

    Topics: Animals; Bacterial Capsules; Chemotaxis, Leukocyte; Escherichia coli; Humans; Interleukin-8; Neutrophils; O Antigens; Oligopeptides; Rats; Rats, Long-Evans

2003